Benjamin Gavish, Ph.D.

Co-Founder and Chief Scientific Officer

Dr. Benjamin Gavish is the inventor of InterCure’s technologies. He co-founded the company in 1994, and is responsible for the company’s research and development, patenting, regulatory applications, and the enrollment of the company’s world-class Scientific Advisory Board.

Dr. Gavish has had numerous appointments, including the Katchalsky Postdoctorate Fellowship at the Weizmann Institute, a Fullbright Fellowship and Assistant Professorship at the University of Illinois, and an Allon Fellowship at the Hebrew University — Hadassah Medical School. Throughout his career, he has concentrated his research activities in biophysics and biomedical engineering with a particular focus on protein biophysics, ultrasound biophysics, small blood vessels, blood rheology, and non-invasive monitoring.

Dr. Gavish is currently working on the mechanisms associated with the therapeutic effect of breathing exercises and on new characterizations of blood vessel properties using non-invasive measurements. He has numerous patents, mainly in biomedical engineering, and has published more than 40 scientific papers, mostly in leading science and technology journals. Dr. Gavish has served as the President and the Secretary of the Israeli Society for Microcirculation, is a member of the International, American and Israeli Societies of Hypertension, and the American Heart Association Council for High Blood Pressure Research. Dr. Gavish received his Ph.D. in Solid State Physics from Tel Aviv University in 1974.